This entry represents the C-terminal Ig-fold domain of Alpha-L-iduronidase enzyme [1-4].

1: Human alpha-L-iduronidase uses its own N-glycan as a substrate-binding and catalytic module. Maita N, Tsukimura T, Taniguchi T, Saito S, Ohno K, Taniguchi H, Sakuraba H; Proc Natl Acad Sci U S A. 2013;110:14628-14633. PMID:23959878

2: Insights into mucopolysaccharidosis I from the structure and action of alpha-L-iduronidase. Bie H, Yin J, He X, Kermode AR, Goddard-Borger ED, Withers SG, James MN; Nat Chem Biol. 2013;9:739-745. PMID:24036510

3: New Irreversible alpha-l-Iduronidase Inhibitors and Activity-Based Probes. Artola M, Kuo CL, McMahon SA, Oehler V, Hansen T, van der Lienden M, He X, van den Elst H, Florea BI, Kermode AR, van der Marel GA, Gloster TM, Codee JDC, Overkleeft HS, Aerts JMFG; Chemistry. 2018;24:19081-19088. PMID:30307091

4: Structure and stability of the designer protein WRAP-T and its permutants. Mylemans B, Lee XY, Laier I, Helsen C, Voet ARD; Sci Rep. 2021;11:18867. PMID:34552189